abstract |
The present invention provides recombinant hematopoietic molecules comprising at least a portion of a first hematopoietic molecule having early myeloid differentiation activity and at least a portion of a second hematopoietic molecule having late myeloid differentiation activity. Nucleic acid molecules encoding such recombinant molecules, as well as pharmaceutical compositions comprising such recombinant factors are also disclosed. |